Li Dongxu, Zhou Xu, Li Mengsi
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, 610041, Sichuan, People's Republic of China.
Evidence-Based Medicine Research Center, Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, People's Republic of China.
Pediatr Cardiol. 2020 Oct;41(7):1376-1385. doi: 10.1007/s00246-020-02386-z. Epub 2020 Jun 3.
We performed this meta-analysis to assess the safety and efficacy of tracheoplasty for patients with pulmonary artery sling (PAS) and tracheal stenosis. Published studies that included surgical treatment of PAS and tracheal stenosis with and without tracheoplasty were identified by searching the PubMed, EMBASE, and Cochrane Library databases until May 2020. The outcomes assessed included postoperative ventilation time, early and late mortality, and follow-up respiratory symptoms. The mean difference (MD)/risk ratio (RR) with 95% confidence intervals (CI) was estimated with a random-effects/fixed-effects model. Subgroup analysis was performed stratified by percentage of patients with tracheal rings. A total of eight studies comprising 219 patients with PAS accompanied by tracheal stenosis were included. The pooled estimates of postoperative ventilation time (MD 17.68, 95% CI 6.38 to 28.98, p < 0.01) and early mortality (RR 3.93, 95% CI 1.55 to 9.95, p < 0.01) favored the repair-only group. Late mortality (RR 1.33, 95% CI 0.48 to 3.68, p = 0.58) and respiratory symptoms (RR 1.51, 95% CI 0.50 to 4.57, p = 0.47) at follow-up showed no significant differences between the groups with repair-only and repair with tracheoplasty. The same results were found in subgroup analyses. For the surgical treatment of PAS with tracheal stenosis, repair without tracheoplasty appears to result in shorter postoperative ventilation time and lower early mortality, with no increase in late mortality or respiratory symptoms at follow-up, compared with concomitant tracheoplasty.
我们进行这项荟萃分析,以评估肺动脉吊带(PAS)合并气管狭窄患者行气管成形术的安全性和有效性。通过检索PubMed、EMBASE和Cochrane图书馆数据库,识别出截至2020年5月发表的包括PAS合并气管狭窄患者接受手术治疗(有或无气管成形术)的研究。评估的结果包括术后通气时间、早期和晚期死亡率以及随访时的呼吸道症状。采用随机效应/固定效应模型估计95%置信区间(CI)的平均差(MD)/风险比(RR)。按气管环患者百分比进行亚组分析。共纳入8项研究,包括219例伴有气管狭窄的PAS患者。术后通气时间(MD 17.68,95%CI 6.38至28.98,p<0.01)和早期死亡率(RR 3.93,95%CI 1.55至9.95,p<0.01)的合并估计值支持单纯修复组。随访时的晚期死亡率(RR 1.33,95%CI 0.48至3.68,p = 0.58)和呼吸道症状(RR 1.51,95%CI 0.50至4.57,p = 0.47)在单纯修复组和气管成形术修复组之间无显著差异。亚组分析也得到了相同的结果。对于合并气管狭窄的PAS手术治疗,与同期气管成形术相比,不进行气管成形术的修复似乎能使术后通气时间更短,早期死亡率更低,随访时晚期死亡率和呼吸道症状无增加。